K. M. Stenson

Long-term outcome of concurrent chemotherapy and reirradiation for recurrent and second primary head-and-neck squamous cell carcinoma

Joseph K. Salama, Everett E. Vokes, Steven J. Chmura et al. · International Journal of Radiation Oncology*Biology*Physics · 2005 · 258 citations

Medicine, Oncology, Radiation Oncology +10

An Attenuated Adenovirus, ONYX-015, As Mouthwash Therapy for Premalignant Oral Dysplasia

Charles M. Rudin, Ezra E.W. Cohen, Vassiliki A. Papadimitrakopoulou et al. · Journal of Clinical Oncology · 2003 · 144 citations

Dentistry, Oncology, Oral Pathology +17

Induction chemotherapy and concurrent chemoradiotherapy for locoregionally advanced head and neck cancer: a multi-institutional phase II trial investigating three radiotherapy dose levels

Joseph K. Salama, K. M. Stenson, Emily O. Kistner et al. · Annals of Oncology · 2008 · 65 citations · Full text

Medicine, Oncology, Radiation Oncology +15

A randomized phase II study of 5-fluorouracil, hydroxyurea, and twice-daily radiotherapy compared with bevacizumab plus 5-fluorouracil, hydroxyurea, and twice-daily radiotherapy for intermediate-stage and T4N0-1 head and neck cancers

Joseph K. Salama, Daniel J. Haraf, K. M. Stenson et al. · Annals of Oncology · 2011 · 62 citations · Full text

Medicine, Oncology, Radiation Oncology +10

Integration of gefitinib (G), into a concurrent chemoradiation (CRT) regimen followed by G adjuvant therapy in patients with locally advanced head and neck cancer (HNC) - a Phase II Trial

Ezra E.W. Cohen, D. Haraf, K. M. Stenson et al. · Journal of Clinical Oncology · 2005 · 41 citations

Medicine, Oncology, Pharmacotherapy +15